Item 2. Management’s Discussion and Analysis
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Certain statements within "Management's Discussion and Analysis of Financial Condition and Results of Operations" are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. The forward-looking statements contained herein are based on current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Factors that might cause such a difference include, among other things, those set forth under "Liquidity and Capital Resources" below and under “Risk Factors” in Part I, Item 1A to our 2024 Form 10-K , which discussion is incorporated herein by reference. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.
Overview
We are primarily a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. In addition, we provide extensive worldwide aftermarket service and support, including spare parts, equipment upgrades and maintenance services to the semiconductor industry. Our product development and manufacturing activities currently occur primarily in the United States and South Korea. Our equipment and service products are highly technical and are sold through a direct sales force in the United States, Europe, and Asia. Consolidation and partnering within the semiconductor manufacturing industry has resulted in a small number of customers representing a substantial portion of our business. Our ten largest customers accounted for 67.3% of total revenue for the three months ended March 31, 2025.
Sales of our systems in the first three months of 2025 were down compared to the same period in the prior year, as customers have moderated the pace of investments into mature process node technologies. The overall mature process segment represented 86% of our shipped systems revenue, with 14% of shipments to dynamic random-access memory (“DRAM”) applicaitons. Power device shipments comprised 39% of total systems revenue with the general mature segment representing 47%, which includes image sensor applications starting with first quarter 2025 results.
For the three months ending March 31, 2025, the geopolitical environment surrounding trade and tariffs did not have a meaningful impact on our financial results. It is difficult to predict the exact timing and magnitude of the tariffs, the duration for which the tariffs will be in place, and the impact the tariffs will have on our customers and suppliers. We are in the process of developing plans to reduce the potential impact of these tariffs by leveraging our global supply chain and manufacturing footprint.
Critical Accounting Estimates
Management’s discussion and analysis of our financial condition and results of operations included herein and in our 2024 Form 10-K are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates and assumptions. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Management has not identified any need to make any material change in, and has not changed, any of our critical accounting estimates and judgments as described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2024 Form 10-K.
20
Table of Contents
Results of Operations
The following table sets forth our results of operations as a percentage of total revenue:
Three months ended
March 31,
2025
2024
Revenue:
Product
94.9
%
96.5
%
Services
5.1
3.5
Total revenue
100.0
100.0
Cost of revenue:
Product
49.1
50.7
Services
4.8
3.3
Total cost of revenue
53.9
54.0
Gross profit
46.1
46.0
Operating expenses:
Research and development
14.1
10.2
Sales and marketing
7.9
6.9
General and administrative
9.0
6.5
Total operating expenses
31.0
23.6
Income from operations
15.1
22.4
Other income (expense):
Interest income
2.9
2.2
Interest expense
(0.7)
(0.5)
Other, net
(0.2)
(0.7)
Total other income
2.0
1.0
Income before income taxes
17.1
23.4
Income tax provision
2.3
2.9
Net income
14.8
%
20.5
%
Revenue
The following table sets forth our product and services revenue:
Three months ended
Period-to-Period
March 31,
Change
2025
2024
$
%
(dollars in thousands)
Revenue:
Product
$
182,824
$
243,418
$
(60,594)
(24.9)
%
Percentage of revenue
94.9
%
96.5
%
Services
9,739
8,954
785
8.8
%
Percentage of revenue
5.1
%
3.5
%
Total revenue
$
192,563
$
252,372
$
(59,809)
(23.7)
%
Product
Product revenue, which includes systems sales, sales of spare parts, product upgrades and used systems, was $182.8 million, or 94.9% of revenue, during the three months ended March 31, 2025, compared with $243.4 million, or 96.5% of revenue, for the three months ended March 31, 2024. The $60.6 million decrease in product revenue for the three-month period ended March 31, 2025, in comparison to the same period in 2024, was primarily driven by a decrease in system sales.
21
Table of Contents
Deferred revenue includes payments received in advance of system sales as well as deferral of revenue from systems sales for installation and other future performance obligations. The total amount of deferred revenue at March 31, 2025 and December 31, 2024 was $139.3 million and $138.2 million, respectively.
Services
Services revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $9.7 million, or 5.1% of revenue, for the three months ended March 31, 2025, compared with $9.0 million, or 3.5% of revenue, for the three months ended March 31, 2024. Although services revenue typically increases with the expansion of the installed base of systems, it can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the need for equipment service.
Revenue Categories used by Management
In addition to the line item revenue categories discussed above, management also regularly disaggregates revenue in the following categories, which it finds relevant and useful:
● Systems and Aftermarket revenues, in which “Aftermarket” is:
A. The portion of Product revenue relating to spare parts, product upgrades and used equipment, combined with
B. Services revenue, which is the labor component of Aftermarket revenues;
(Aftermarket purchases reflect current fab utilization as opposed to Systems purchases which reflect capital investment decisions by our customers, which have differing economic drivers);
● Revenue by geographic regions, since economic factors impacting customer purchasing decisions may vary by geographic region; and
● Revenue by our customer market segments, since they can be subject to different economic drivers at different periods of time, impacting a customer’s likelihood of purchasing capital equipment during any particular period. Currently, management references three customer market segments: memory, mature process technology and leading edge foundry and logic.
Aftermarket and Systems Revenue
Included in total revenue of $192.6 million during the three months ended March 31, 2025 is revenue from our Aftermarket business of $55.0 million, compared with $56.9 million of Aftermarket revenue for the three months ended March 31, 2024. Aftermarket revenue fluctuates from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the sale of spare parts and demand for equipment service. Aftermarket revenue can also fluctuate from period to period based on the demand for system upgrades or used equipment. The remaining $137.6 million of revenue for the three months ended March 31, 2025 was systems revenue, compared with $195.5 million of systems revenue for the three months ended March 31, 2024. Systems revenue fluctuates from period to period based on our customers’ capital spending.
22
Table of Contents
Gross Profit / Gross Margin
The following table sets forth our gross profit / gross margin:
Three months ended
Period-to-Period
March 31,
Change
2025
2024
$
%
(dollars in thousands)
Gross Profit:
Product
$
88,324
$
115,506
$
(27,182)
(23.5)
%
Product gross margin
48.3
%
47.5
%
Services
444
545
(101)
(18.5)
%
Services gross margin
4.6
%
6.1
%
Total gross profit
$
88,768
$
116,051
$
(27,283)
(23.5)
%
Gross margin
46.1
%
46.0
%
Product
Gross margin from product revenue was 48.3% for the three months ended March 31, 2025, compared to 47.5% for the three months ended March 31, 2024. The increase in gross margin primarily resulted from a favorable mix of system revenue.
Services
Gross margin from services revenue was 4.6% for the three months ended March 31, 2025, compared to 6.1% for the three months ended March 31, 2024. The decrease in gross margin is attributable to changes in the mix of service contracts .
Operating Expenses
The following table sets forth our operating expenses:
Three months ended
Period-to-Period
March 31,
Change
2025
2024
$
%
(dollars in thousands)
Research and development
$
27,128
$
25,662
$
1,466
5.7
%
Percentage of revenue
14.1
%
10.2
%
Sales and marketing
15,124
17,445
(2,321)
(13.3)
%
Percentage of revenue
7.9
%
6.9
%
General and administrative
17,357
16,405
952
5.8
%
Percentage of revenue
9.0
%
6.5
%
Total operating expenses
$
59,609
$
59,512
$
97
0.2
%
Percentage of revenue
31.0
%
23.6
%
Our operating expenses consist primarily of personnel costs, including wages, commissions, incentive-based compensation, stock-based compensation and related benefits and taxes; project material costs related to the design and development of new products and enhancement of existing products; and professional fees, travel and depreciation expenses.
Personnel costs are our largest expense, representing $35.4 million, or 59.4%, of our total operating expenses for the three months ended March 31, 2025, compared to $36.4 million, or 61.2%, of our total operating expenses for the three months ended March 31, 2024. The lower personnel costs for the three months ended March 31, 2025 are primarily due to a decrease in variable compensation expense and commissions, partially offset by increases in wages, stock-based compensation, and separation program expenses.
23
Table of Contents
Research and Development
Three months ended
Period-to-Period
March 31,
Change
2025
2024
$
%
(dollars in thousands)
Research and development
$
27,128
$
25,662
$
1,466
5.7
%
Percentage of revenue
14.1
%
10.2
%
Our ability to remain competitive depends largely on continuously developing innovative technology, with new and enhanced features and systems and introducing them at competitive prices on a timely basis. Accordingly, based on our strategic plan, we establish annual research and development budgets to fund programs that we expect will solve customers’ high value, high impact, ion implantation challenges.
Research and development expense was $27.1 million during the three months ended March 31, 2025, an increase of $1.5 million, or 5.7%, compared with $25.7 million during the three months ended March 31, 2024. The increase is primarily due to higher project and consulting expenses and depreciation expense.
Sales and Marketing
Three months ended
Period-to-Period
March 31,
Change
2025
2024
$
%
(dollars in thousands)
Sales and marketing
$
15,124
$
17,445
$
(2,321)
(13.3)
%
Percentage of revenue
7.9
%
6.9
%
Our sales and marketing expenses result primarily from the sale of our equipment and services through our direct sales force.
Sales and marketing expense was $15.1 million during the three months ended March 31, 2025, a decrease of $2.3 million, or 13.3%, compared with $17.4 million during the three months ended March 31, 2024. The decrease is primarily due to a decrease in variable compensation and tool evaluation costs.
General and Administrative
Three months ended
Period-to-Period
March 31,
Change
2025
2024
$
%
(dollars in thousands)
General and administrative
$
17,357
$
16,405
$
952
5.8
%
Percentage of revenue
9.0
%
6.5
%
Our general and administrative expenses result primarily from the costs associated with our executive, finance, information technology, legal and human resource functions.
General and administrative expense was $17.4 million during the three months ended March 31, 2025, an increase of $1.0 million, or 5.8%, compared with $16.4 million during the three months ended March 31, 2024. The increase is primarily due to professional fees and the recovery of a previously written-off receivable in the prior year period.
24
Table of Contents
Other Income (Expense)
Three months ended
Period-to-period
March 31,
change
2025
2024
$
%
(dollars in thousands)
Other income (expense):
$
3,925
$
2,460
$
1,465
59.6
%
Percentage of revenue
2.0
%
1.0
%
Other income (expense) consists of interest earned and accretion on our invested cash balances, interest expense relating to the finance lease obligation we incurred in connection with the 2015 sale of our headquarters facility and other financing obligations as well as foreign exchange gains and losses attributable to both fluctuations of the U.S. dollar against local currencies of the countries in which we operate and forward currency exchange contracts.
Other income was $3.9 million for the three months ended March 31, 2025, compared with other income of $2.5 million for the three months ended March 31, 2024. The $1.5 million increase in other income (expense) compared to the same prior year period was primarily due to a decrease in net foreign exchange losses of $1.4 million. Net foreign exchange losses for the three months ended March 31, 2025 includes $1.2 million of losses related to forward currency exchange contracts, partially offset by foreign exchange gains of $0.8 million. Net foreign exchange losses for the three months ended March 31, 2024 includes foreign exchange losses of $3.3 million, partially offset by foreign exchange gains of $1.5 million from forward currency exchange contracts.
Income Tax Provision
Three months ended
Period-to-period
March 31,
change
2025
2024
$
%
(dollars in thousands)
Income tax provision
$
4,505
$
7,404
$
(2,899)
(39.2)
%
Percentage of revenue
2.3
%
2.9
%
Income tax expense was $4.5 million for the three months ended March 31, 2025, compared to $7.4 million for the three months ended March 31, 2024. The $2.9 million decrease was primarily due to a decrease in pre-tax book income.
The ETR for the three months ended March 31, 2025 was less than the U.S. statutory rate of 21% primarily attributable to Foreign Derived Intangible Income deduction and Federal research and development tax credits. The reported ETR for the three months ended March 31, 2025 was 13.6% compared to 12.5% for the respective 2024 period. The increase in the reported ETR is primarily related to a decrease in pre-tax book income and stock-based compensation.
Liquidity and Capital Resources
At March 31, 2025, we had $184.0 million in unrestricted cash and cash equivalents and $403.1 million in short-term investments, in addition to $7.6 million in restricted cash. Management believes that maintaining a strong cash balance is necessary to fund a continuing ramp in our business which can require significant cash investment to meet sudden demand. Additionally, we are using cash to repurchase shares as part of our stock repurchase program and are considering both organic and inorganic opportunities to drive future growth, for which cash resources will be necessary.
Our liquidity is affected by many factors. Some of these relate specifically to the operations of our business, for example, the rate of sales of our products, and others relate to the uncertainties of global economic conditions, including tariff programs implemented in countries in which we operate as well as the availability of credit and the condition of the overall semiconductor equipment industry. Our industry requires ongoing investments in operations and research and development that are not easily adjusted to reflect changes in revenue. As a result, profitability and cash flows can fluctuate more widely than revenue. Stock repurchases, as discussed below, also reduce our cash balances.
During the three months ended March 31, 2025 and 2024, we generated $39.8 million and $42.2 million, respectively, of cash related to operating activities.
Investing activities for the three months ended March 31, 2025 resulted in cash generated of $40.5 million, $5.0 million of which was used for capital expenditures and $252.5 million of which was used to purchase short-term
25
Table of Contents
investments, offset by $297.9 million related to maturities and sales of short-term investments. Investing activities for the three months ended March 31, 2024 resulted in cash outflows of $55.7 million, $1.6 million of which was used for capital expenditures and $145.1 million of which was used to purchase short-term investments, offset by $91.1 million related to maturities of short-term investments.
Financing activities for the three months ended March 31, 2025 resulted in a cash usage of $20.1 million. During the first three months of 2025, (i) $18.2 million in cash was used to repurchase our common stock, (ii) $1.6 million was used for payments to government tax authorities for income tax withholding on employee compensation arising from the vesting of RSUs, where units are withheld by us to cover taxes, and (iii) $0.3 million was used to reduce the liability under the finance lease of our corporate headquarters. In comparison, financing activities for the three months ended March 31, 2024 resulted in cash usage of $18.1 million, of which (i) $15.0 million related to the repurchase of our common stock (ii) $2.7 million related to payments made to government tax authorities for income tax withholding on employee compensation arising from the vesting of RSUs, and (iii) $0.4 million relating to the reduction of our finance lease liability.
As of March 31, 2025, we had a security deposit of $5.9 million related to the lease of our corporate headquarters in the form of a cash collateralized letter of credit issued with UBS Bank USA, which is classified as long-term restricted cash on our balance sheet.
We believe that based on our current market, revenue, expense and cash flow forecasts, our existing cash and cash equivalents will be sufficient to satisfy our anticipated cash requirements for the short- and long-term.
Commitments and Contingencies
Significant commitments and contingencies at March 31, 2025 are consistent with those discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 16 to the consolidated financial statements included in our 2024 Form 10-K.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
As of March 31, 2025, there have been no material changes to the quantitative information about market risk disclosed in Item 7A, “Quantitative and Qualitative Disclosures about Market Risk” included in our 2024 Form 10-K.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.